SEQanswers

Go Back   SEQanswers > Events / Conferences



Similar Threads
Thread Thread Starter Forum Replies Last Post
Genomics for Decision Making During Drug Development and Clinical Trials jhodges Events / Conferences 0 02-07-2013 12:31 PM
Preliminary agenda announced for TCGC: The Clinical Genomics Conference 2013 Pavolga Events / Conferences 0 02-05-2013 12:08 PM
Setting up a clinical genomics lab Spena Bioinformatics 0 06-20-2011 07:11 PM

Reply
 
Thread Tools
Old 03-08-2013, 08:47 AM   #1
jhodges
Member
 
Location: New England

Join Date: Nov 2012
Posts: 14
Default Genomics for Drug Discovery, Validation and Clinical Development with AstraZeneca, Pf

In just two weeks, Cambridge Healthtech Institute's NGS for Drugs, Patients and Clinical Trials will feature a series of opening discussions focused on the utilization of genomic data for decision making during drug development, including steps for discerning and validating targets, model selection, biomarker development, patient stratification and CAP/CLIA-certified operations.

Join leaders from Pfizer, AstraZeneca, Sanofi, Gilead, Genedata and Washington University, as they share their first-hand experiences using genomic information for data driven decision making.

Featured Session Presentations:

Profiling and NGS in Cancer: Challenges and Applications to Targets, Models, and Resistance
Paul Rejto, Ph.D., Director, Computational Biology, Oncology Research Unit, Pfizer, Inc.

Impact of Next-Generation Sequencing on Oncology Drug Discovery and Early Clinical Development
Oleg Iartchouk, Ph.D., Lead Scientist and Lab Head, Applied Genomics, Translational and Experimental Medicine, Sanofi

Uncovering Genetic Interactions in Tumor Cell Lines: A Workflow-Based Approach for NGS Analysis
Benjamin J. Adamczyk, Ph.D., Scientific Account Manager, Genedata USA, Inc.

Devising Methods for Intuitively Handling Huge Data Sets to Simplify Biomarker Discovery
Dongliang Ge, Ph.D., Director, Bioinformatics, Gilead Sciences, Inc.

Stratification of Clinical Trial Subjects Using Biomarkers Developed by Next-Generation Sequencing
Brian Dougherty, Ph.D., Lead, Translational Genomics, Oncology, AstraZeneca

From Theory to Practice: Our First Thousand Samples
Seth D. Crosby, M.D., Director, Alliances and Partnerships, Department of Genetics, Washington University School of Medicine

NGS for Drugs, Patients and Clinical Trials
March 21-22, 2013
Hilton San Diego Resort
Learn more at healthtech.com/ngs-drug-development
jhodges is offline   Reply With Quote
Reply

Tags
drug discovery, genomics, next-gen sequencing

Thread Tools

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off




All times are GMT -8. The time now is 09:24 AM.


Powered by vBulletin® Version 3.8.9
Copyright ©2000 - 2019, vBulletin Solutions, Inc.
Single Sign On provided by vBSSO